Substituted hetero-polycyclic compounds as PPAR&agr; and PPAR&ggr; activators
US6468996B1 · kind B1 · utility
25Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 19, 1999 |
| Grant date | Oct 22, 2002 |
| Priority date | — |
| Expiry date | Oct 19, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D279/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the general formula (I) The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.